Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ALMS, CGON, IRON, NTRA, LYEL, and represent 92.43% of Foresite Capital Management V's stock portfolio.
  • Added to shares of these 1 stock: NTRA (+$15M).
  • Started 1 new stock position in NTRA.
  • Foresite Capital Management V was a net buyer of stock by $15M.
  • Foresite Capital Management V has $164M in assets under management (AUM), dropping by 51.18%.
  • Central Index Key (CIK): 0001792206

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Foresite Capital Management V holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alumis (ALMS) 34.3 $56M 5.8M 9.76
 View chart
Cg Oncology (CGON) 25.4 $42M 1.0M 41.52
 View chart
Disc Medicine (IRON) 14.4 $24M 299k 79.41
 View chart
Natera (NTRA) 9.4 $15M NEW 67k 229.09
 View chart
Lyell Immunopharma (LYEL) 8.9 $15M 477k 30.78
 View chart
Hims & Hers Health Com Cl A (HIMS) 5.4 $8.9M 273k 32.47
 View chart
Maze Therapeatics (MAZE) 2.2 $3.6M 86k 41.43
 View chart

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020

View all past filings